Pilot study of vitaxin--an angiogenesis inhibitor-in patients with advanced leiomyosarcomas

S R Patel1, J Jenkins, N Papadopolous

  • 1Department of Sarcoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. spatel@mdanderson.org

Cancer
|September 26, 2001
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos